Suivre
Bertrand Lell
Bertrand Lell
Center de Recherches Medicales de Lambarene
Adresse e-mail validée de cermel.org - Page d'accueil
Titre
Citée par
Citée par
Année
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
1018*2011
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
9742015
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10
AHJ van den Biggelaar, R van Ree, LC Rodrigues, B Lell, AM Deelder, ...
The Lancet 356 (9243), 1723-1727, 2000
9132000
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
RTS, S Clinical Trials Partnership
New England Journal of Medicine 367 (24), 2284-2295, 2012
835*2012
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
4962016
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
4102015
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial
M Adjuik, P Agnamey, A Babiker, S Borrmann, P Brasseur, M Cisse, ...
The Lancet 359 (9315), 1365-1372, 2002
4032002
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
3382014
Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ...
The Lancet infectious diseases 15 (12), 1450-1458, 2015
3342015
Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children
AJF Luty, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, B Greve, ...
The Journal of infectious diseases 179 (4), 980-988, 1999
3231999
Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria
AJF Luty, DJ Perkins, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, ...
Infection and immunity 68 (7), 3909-3915, 2000
3152000
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled …
JJ Aponte, D Schellenberg, A Egan, A Breckenridge, I Carneiro, ...
The Lancet 374 (9700), 1533-1542, 2009
3012009
Fosmidomycin, a novel chemotherapeutic agent for malaria
B Lell, R Ruangweerayut, J Wiesner, MA Missinou, A Schindler, ...
Antimicrobial agents and chemotherapy 47 (2), 735-738, 2003
2952003
Fosmidomycin for malaria
MA Missinou, S Borrmann, A Schindler, S Issifou, AA Adegnika, ...
The Lancet 360 (9349), 1941-1942, 2002
2822002
The role of red blood cell polymorphisms in resistance and susceptibility to malaria
B Lell, J May, RJ Schmidt-Ott, LG Lehman, D Luckner, B Greve, ...
Clinical Infectious Diseases 28 (4), 794-799, 1999
2431999
Clindamycin as an antimalarial drug: review of clinical trials
B Lell, PG Kremsner
Antimicrobial agents and chemotherapy 46 (8), 2315-2320, 2002
2312002
Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria
JFJ Kun, B Mordmüller, B Lell, LG Lehman, D Luckner, PG Kremsner
The Lancet 351 (9098), 265-266, 1998
2241998
COVID-19 in Africa: Dampening the storm?
M Mbow, B Lell, SP Jochems, B Cisse, S Mboup, BG Dewals, A Jaye, ...
Science 369 (6504), 624-626, 2020
2032020
Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon
JFT Kun, RJ Schmidt-Ott, LG Lehman, B Lell, D Luckner, B Greve, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 92 (1 …, 1998
1931998
Plasma Interleukin-10: Tumor Necrosis Factor (TNF)—α Ratio Is Associated with TNF Promoter Variants and Predicts Malarial Complications
J May, B Lell, AJF Luty, CG Meyer, PG Kremsner
The Journal of infectious diseases 182 (5), 1570-1573, 2000
1682000
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20